Detecting Adverse Drug Events with Rapidly Trained Classification Models.
Alec B ChapmanKelly S PetersonPatrick R AlbaScott L DuVallOlga V PattersonPublished in: Drug safety (2019)
Adding to the growing number of publications that utilize NLP to detect occurrences of ADEs, our study illustrates the benefits of employing innovative feature engineering.